Validation of the Drug Abuse Screening Test (DAST-10): A study on illicit drug use among Chinese pregnant women.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

Original Publication: London : Nature Publishing Group, copyright 2011-

Substance Abuse Detection/*methods ; Substance Abuse Detection/*standards ; Substance-Related Disorders/*diagnosis ; Substance-Related Disorders/*epidemiology; Adult ; China/epidemiology ; Female ; Humans ; Illicit Drugs ; Pregnancy ; ROC Curve ; Reproducibility of Results ; Sensitivity and Specificity

We assessed the Chinese version of the Drug Abuse Screening Test (DAST-10) for identifying illicit drug use during pregnancy among Chinese population. Chinese pregnant women attending their first antenatal visit or their first unbooked visit to the maternity ward were recruited during a 4-month study period in 2011. The participants completed self-administered questionnaires on demographic information, a single question on illicit drug use during pregnancy and the DAST-10. Urine samples screened positive by the urine Point-of-Care Test were confirmed by gas chromatography-mass spectrometry. DAST-10 performance was compared with three different gold standards: urinalysis, self-reported drug use, and evidence of drug use by urinalysis or self-report. 1214 Chinese pregnant women participated in the study and 1085 complete DAST-10 forms were collected. Women who had used illicit drugs had significantly different DAST-10 scores than those who had not. The sensitivity of DAST-10 for identify illicit drug use in pregnant women ranged from 79.2% to 33.3% and specificity ranged from 67.7% to 99.7% using cut-off scores from ≥ 1 to ≥ 3. The ~ 80% sensitivity of DAST-10 using a cut-off score of ≥ 1 should be sufficient for screening of illicit drug use in Chinese pregnant women, but validation tests for drug use are needed.

Psychol Assess. 2000 Jun;12(2):186-92. (PMID: 10887764)
J Clin Psychiatry. 2003 Jul;64(7):767-74. (PMID: 12934976)
Addict Behav. 1982;7(4):363-71. (PMID: 7183189)
Aust N Z J Obstet Gynaecol. 1992 Aug;32(3):216-21. (PMID: 1445130)
Subst Use Misuse. 1996 Jul;31(9):1131-53. (PMID: 8853234)
J Perinatol. 1996 Sep-Oct;16(5):326-30. (PMID: 8915928)
Ann N Y Acad Sci. 1998 Jun 21;846:329-34. (PMID: 9668419)
J Perinatol. 2005 Jun;25(6):368-74. (PMID: 15703775)
J Reprod Med. 2006 Jul;51(7):567-72. (PMID: 16913548)
J Subst Abuse Treat. 2007 Mar;32(2):189-98. (PMID: 17306727)
Curr Opin Obstet Gynecol. 2007 Dec;19(6):578-85. (PMID: 18007137)
Mayo Clin Proc. 2008 Jan;83(1):66-76. (PMID: 18174009)
J Perinatol. 2008 Sep;28(9):597-603. (PMID: 18580882)
Yonsei Med J. 2008 Oct 31;49(5):705-13. (PMID: 18972589)
Arch Intern Med. 2010 Jul 12;170(13):1155-60. (PMID: 20625025)
Psychol Addict Behav. 2010 Dec;24(4):719-23. (PMID: 21198230)
Am J Obstet Gynecol. 2011 Sep;205(3):219.e1-7. (PMID: 21658669)
Addiction. 2012 Dec;107(12):2099-106. (PMID: 22882721)
Addiction. 2013 Jan;108(1):3-8. (PMID: 22563741)
Environ Int. 2013 Apr;54:141-63. (PMID: 23454110)
Addiction. 2013 May;108(5):1002. (PMID: 23587087)
Pediatrics. 2013 Jun;131(6):e1917-36. (PMID: 23713107)
J Midwifery Womens Health. 2013 May-Jun;58(3):278-87. (PMID: 23631601)

0 (Illicit Drugs)

Date Created: 20150620 Date Completed: 20160607 Latest Revision: 20191210

20240829

PMC4473689

10.1038/srep11420

26091290